4-[[1-[(2,6-dichlorophenyl)sulfonyl-methylamino]cyclopropanecarbonyl]amino]adamantane-1-carboxamide
C22H27Cl2N3O4S — CID 71543143
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[1-[(2,6-dichlorophenyl)sulfonyl-methylamino]cyclopropanecarbonyl]amino]adamantane-1-carboxamide
4-[[1-[(2,6-dichlorophenyl)sulfonyl-methylamino]cyclopropanecarbonyl]amino]adamantane-1-carboxamide (PubChem CID 71543143) has the molecular formula C22H27Cl2N3O4S and a molecular weight of 500.45 g/mol. Its IUPAC name is 4-[[1-[(2,6-dichlorophenyl)sulfonyl-methylamino]cyclopropanecarbonyl]amino]adamantane-1-carboxamide.
Molecular Properties
| Compound Name | 4-[[1-[(2,6-dichlorophenyl)sulfonyl-methylamino]cyclopropanecarbonyl]amino]adamantane-1-carboxamide |
|---|---|
| PubChem CID | 71543143 |
| Molecular Formula | C22H27Cl2N3O4S |
| Molecular Weight | 500.45 g/mol |
| Exact Mass | 499.11 |
| IUPAC Name | 4-[[1-[(2,6-dichlorophenyl)sulfonyl-methylamino]cyclopropanecarbonyl]amino]adamantane-1-carboxamide |
| SMILES | CN(C1(C(=O)NC2C3CC4CC2CC(C(N)=O)(C4)C3)CC1)S(=O)(=O)c1c(Cl)cccc1Cl |
| InChI | InChI=1S/C22H27Cl2N3O4S/c1-27(32(30,31)18-15(23)3-2-4-16(18)24)22(5-6-22)20(29)26-17-13-7-12-8-14(17)11-21(9-12,10-13)19(25)28/h2-4,12-14,17H,5-11H2,1H3,(H2,25,28)(H,26,29) |
| InChIKey | PNGMXPUDBBNGRF-UHFFFAOYSA-N |
| XLogP | 2.94 |
| TPSA | 109.57 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 500.45 |
| LogP ≤ 5 | 2.94 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 71543143 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.